FDA Makes Midthun Analgesic/Anti-Inflammatory Division Permanent Director

FDA ends a four-year search for a permanent director of its Anti-Inflammatory, Analgesic & Ophthalmologic Drug Products Division with the appointment of Karen Midthun, MD to division director Dec. 17.